enGene Holdings Target Price

Analysts' average 12-month price target for enGene Holdings is $3.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.69

Average Target Price

$3.00

77.5% upside

7 analysts in the last 4 months

High: $4 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-18	Morgan StanleyJudah Frommer	$3	77.5% upside
2026-06-16	H.C. WainwrightAndres Maldonado	$4	136.7% upside
2026-05-14	UBS	$2	18.3% upside
2026-05-08	Leerink PartnersMarket Perform	$2	18.3% upside
2026-05-08	Raymond James	$4	136.7% upside
2026-05-08	Piper SandlerAllison Bratzel	$4	136.7% upside
2026-05-08	Wells Fargo	$2	18.3% upside
2026-03-09	Raymond JamesSean McCutcheon	$27	1497.6% upside
2026-01-30	Jefferies	$28	1556.8% upside
2025-12-03	H.C. WainwrightAndres Maldonado	$25	1379.3% upside
2025-11-12	OppenheimerLeland Gershell	$33	1852.7% upside
2025-11-12	UBS	$10	491.7% upside
2024-11-18	JMP SecuritiesSilvan Tuerkcan	$18	965.1% upside
2024-09-27	Leerink PartnersMani Foroohar	$17	905.9% upside

enGene Holdings (ENGN) FAQ

enGene Holdings posts a target price of $3. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $3 for ENGN means covering analysts, on average, see the stock 77.5% upside of $1.69 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ENGN's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; enGene Holdings's other metric pages and overview cover the third.